Next 10 |
2024-05-20 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Amid the rise of the digital innovation space, investors may want to consider biotech stocks to buy. Fundamentally, a rotation into the sector may occur, boding well for the ecosystem befor...
2024-05-07 23:03:10 ET Ligand Pharmaceuticals Incorporated (LGND) Q1 2024 Earnings Conference Call May 07, 2024 04:30 PM ET Company Participants Michael Jeong - Investor Relations Todd Davis - Chief Executive Officer Paul Hadden - Senior Vice President, Investmen...
2024-05-07 16:52:18 ET More on Ligand Pharmaceuticals Ligand Pharmaceuticals Incorporated 2024 Q1 - Results - Earnings Call Presentation Ligand: Buy This Pharma Royalty Aggregator To Generate Growth In Your Portfolio Ligand Pharmaceuticals Inc. (LGND) Q4 2023 Earning...
Conference Call Begins at 4:30 p.m. Eastern Time Today Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three months ended March 31, 2024, and provided an operating forecast and business updates. Ligand management will host a conference cal...
2024-05-07 08:02:01 ET More on Ligand Pharmaceuticals Ligand: Buy This Pharma Royalty Aggregator To Generate Growth In Your Portfolio Ovid Therapeutics gains on bullish view at Wedbush Seeking Alpha’s Quant Rating on Ligand Pharmaceuticals Read the f...
Capital infusion will support botensilimab and balstilimab (BOT/BAL) clinical development, confirmatory Phase 3 trial, and launch readiness activities Ligand entitled to royalties and milestone payments on six Agenus-partnered programs as well as royalties on future global net sales gener...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...
2024-05-02 15:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-29 22:01:18 ET Summary Royalty Aggregators like Royalty Pharma, Ligand, and XOMA are gaining popularity in the biotech industry. These companies buy up royalty rights to pharmaceutical products, providing upfront cash to biotech companies. This allows biotech companies...
2024-04-25 10:05:00 ET Summary Tourlite Capital Management, LP is an asset management firm focused on long/short equity investing in public companies. Tourlite Fund, LP returned 6.0% for the First Quarter of 2024. The Fund has annualized returns of 10.0% since inception, compa...
News, Short Squeeze, Breakout and More Instantly...
Ligand Pharmaceuticals Incorporated Company Name:
LGND Stock Symbol:
NASDAQ Market:
Roche (OTC: RHHBY) obtained a Breakthrough Therapy Designation for its investigational oral therapy inavolisib for treating adult breast cancer pat...
Shares of Ionis Pharmaceuticals (NASDAQ: IONS) and Biogen (NASDAQ: BIIB) lost at least 2% in market cap on Thursday after the companies announced t...